低度可疑多参数前列腺磁共振成像或良性磁共振成像引导活检后的临床结局:用于检测前列腺癌
研究纳入289名既往系统活检阴性的男性,其中194例低度可疑磁共振成像或靶向活检良性者随访至少3年。中位47个月随访期间38/194(20%)检出前列腺癌,磁共振排除任何和显著前列腺癌的阴性预测值分别为80%和95%。低度可疑磁共振成像者无Gleason评分大于6的中高危癌,作者认为可避免立即重复活检。
要点
- 低度可疑磁共振成像排除显著前列腺癌的阴性预测值为95%(184/194)。
- 随访中位47个月,38/194(20%)检出前列腺癌,无Gleason评分大于6者。
- 无癌随访者中132/156(85%)前列腺特异抗原下降,可在初级保健监测。
核心结论
- 既往系统活检阴性男性中,低度可疑磁共振成像排除长期显著前列腺癌的阴性预测值高,立即重复活检临床价值有限,即使前列腺特异抗原持续升高也可避免。
研究设计与样本
- 前瞻性纳入289名既往系统活检阴性男性,基线行磁共振成像后重复系统与靶向活检,194例低度可疑磁共振成像或靶向活检良性者纳入分析,前列腺癌阴性者随访至少3年。
主要发现
- 中位随访47个月(IQR 43-52),194例中38例(20%)检出前列腺癌。
- 磁共振排除任何前列腺癌的阴性预测值为80%(156/194),排除显著前列腺癌的阴性预测值为95%(184/194)。
- 低度可疑磁共振成像者无Gleason评分大于6的中高危癌。
- 随访无癌者中132/156(85%)前列腺特异抗原下降,可在初级保健监测。
关键数值与推荐
- 显著前列腺癌定义为任何针道Gleason评分大于6,或超过2个阳性针道/癌组织占针道50%以上。
临床怎么用
- 作者认为,既往系统活检阴性且磁共振低度可疑者,立即重复活检临床价值有限,即使前列腺特异抗原持续升高也可避免。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed the risk of significant prostate cancer being detected after low suspicion magnetic resonance imaging or suspicious magnetic resonance imaging with benign magnetic resonance imaging guided biopsies in men with prior negative systematic biopsies. MATERIALS AND METHODS: Overall 289 prospectively enrolled men underwent magnetic resonance imaging followed by repeat systematic and targeted biopsies of any suspicious lesions at baseline. A total of 194 patients with low suspicion magnetic resonance imaging or benign target biopsies were suitable for this study. Those who were negative for prostate cancer at baseline were followed for at least 3 years. We calculated the negative predictive values of magnetic resonance imaging in ruling out any prostate cancer and significant prostate cancer, defined as any core with Gleason score greater than 6, or more than 2 positive cores/cancerous core 50% or greater. RESULTS: Prostate cancer was detected in 38 of 194 (20%) patients during the median study period of 47 months (IQR 43-52). The overall negative predictive value of magnetic resonance imaging in ruling out any and significant prostate cancer was 80% (156 of 194) and 95% (184 of 194), respectively. No patient with low suspicion magnetic resonance imaging had intermediate/high grade cancer (Gleason score greater than 6). The majority of patients with no cancer during followup (132 of 156, 85%) had a decreasing prostate specific antigen and could be monitored in primary care. CONCLUSIONS: Low suspicion magnetic resonance imaging in men with prior negative systematic biopsies has a high negative predictive value in ruling out longer term, significant cancer. Therefore, immediate repeat biopsies are of limited clinical value and could be avoided even if prostate specific antigen is persistently increased.
引用
- Boesen L, Nørgaard N, Løgager V, et al. Clinical Outcome Following Low Suspicion Multiparametric Prostate Magnetic Resonance Imaging or Benign Magnetic Resonance Imaging Guided Biopsy to Detect Prostate Cancer. J Urol. 2017. PMID: 28235549. doi:10.1016/j.juro.2017.02.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。